Key facts
- This page summarizes Michael Heltzen's Form 4 filing for EXOZYMES INC. (EXOZ).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 20 Jun 2025, 12:31.
Michael Heltzen - 17 Jun 2025 Form 4 Insider Report for EXOZYMES INC. (EXOZ)
- Reporting relationship
- Chief Executive Officer
- Issuer ticker
- EXOZ
- Reported as of
- 17 Jun 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 20 Jun 2025, 12:31:31 UTC
- Prior SEC filing
- 21 Jan 2025
- Next SEC filing
- 02 Jul 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael Heltzen
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Michael Heltzen filed Form 4 for EXOZYMES INC. (EXOZ) on 20 Jun 2025.
Change
- Previous filing in this sequence was filed on 21 Jan 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002030840
Primary reporting owner
Heltzen Michael
- Relationship
- Chief Executive Officer
- Address
- C/O 750 ROYAL OAKS DRIVE, SUITE 106, MONROVIA
- Signature
- /s/ Michael Heltzen
- Signature date
- 20 Jun 2025
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
EXOZ
transaction
Derivative
Stock Options for Common Stock
Award
- Transaction value
- $0
- Shares
- +235,817
- Change %
- Price
- $0.000000
- Shares after
- 235,817
- Date
- 17 Jun 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 235,817
- Exercise price
- $12.40
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The Options will vest over a four (4) year period, in equal quarterly installments at the end of each quarter of the calendar year, and the Options will commence vesting on July 1, 2025.The option expires June 29, 2032.